|
ZNF587 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.98859842323895E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.79939999859158E-08 |
| Normal-vs-Stage2 |
6.9373000011197E-08 |
| Normal-vs-Stage3 |
5.16469977895895E-10 |
| Normal-vs-Stage4 |
7.67389995992573E-09 |
| Stage1-vs-Stage2 |
1.198770E-01 |
| Stage1-vs-Stage3 |
4.571500E-02 |
| Stage1-vs-Stage4 |
4.105600E-02 |
| Stage2-vs-Stage3 |
9.407200E-01 |
| Stage2-vs-Stage4 |
9.532400E-01 |
| Stage3-vs-Stage4 |
8.873200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43690004339447E-09 |
| Normal-vs-AfricanAmerican |
4.158400E-03 |
| Normal-vs-Asian |
2.13229999999065E-05 |
| Caucasian-vs-AfricanAmerican |
3.529000E-01 |
| Caucasian-vs-Asian |
7.331400E-01 |
| AfricanAmerican-vs-Asian |
5.274800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10929998309706E-09 |
| Normal-vs-Female |
2.70560018833521E-10 |
| Male-vs-Female |
6.971200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.28020000045304E-07 |
| Normal-vs-Age(41-60Yrs) |
2.88180002083749E-09 |
| Normal-vs-Age(61-80Yrs) |
3.02900038384735E-10 |
| Normal-vs-Age(81-100Yrs) |
2.106500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.157200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.352100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.197000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.008800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.616200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.758600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.009320E-04 |
| Classical-VS-Follicular |
7.626100E-04 |
| Classical-VS-Other |
3.870200E-01 |
| Classical-VS-Normal |
6.07490000525956E-08 |
| Tall-VS-Follicular |
3.815200E-01 |
| Tall-VS-Other |
6.034200E-01 |
| Tall-VS-Normal |
2.58789989437958E-10 |
| Follicular-VS-Other |
8.067200E-01 |
| Follicular-VS-Normal |
1.00969999028422E-09 |
| Other-VS-Normal |
1.222390E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.30580040908535E-10 |
| Normal-vs-N1 |
1.15400000000321E-06 |
| N0-vs-N1 |
8.342800E-01 |
|
|
